ng-nitroarginine methyl ester has been researched along with Gait Disorders, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagwell, JM; Csiszar, A; Farkas, E; Fülöp, GA; Hertelendy, P; Kiss, T; O'Connor, D; Sorond, F; Tarantini, S; Ungvari, Z; Valcarcel-Ares, MN; Yabluchanksiy, A | 1 |
| Hillier, C; Keen, JA; McGorum, BC; Nally, JE | 1 |
| Nolan, AM; Pawson, P; Reid, J | 1 |
3 other study(ies) available for ng-nitroarginine methyl ester and Gait Disorders, Animal
| Article | Year |
|---|---|
Pharmacologically induced impairment of neurovascular coupling responses alters gait coordination in mice.
Topics: Animals; Cerebrovascular Circulation; Cognition Disorders; Cyclooxygenase Inhibitors; Disease Models, Animal; Gait; Indomethacin; Lameness, Animal; Male; Maze Learning; Mice; Mice, Inbred C57BL; Neurovascular Coupling; NG-Nitroarginine Methyl Ester; Random Allocation; Sensitivity and Specificity | 2017 |
Endothelin mediated contraction of equine laminar veins.
Topics: Animals; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Foot Diseases; Hoof and Claw; Horse Diseases; Horses; Lameness, Animal; Muscle Contraction; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Oligopeptides; Peptides, Cyclic; Piperidines; Receptor, Endothelin A; Receptor, Endothelin B; Veins | 2008 |
The role of nitric oxide in the responses of the ovine digital artery to vasoactive agents and modification of these responses by endotoxin and cytokines.
Topics: Animals; Arteries; Bradykinin; Cytokines; Endothelium, Vascular; Endotoxins; Enzyme Inhibitors; Forelimb; Lameness, Animal; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phenylephrine; Sheep; Vasoconstrictor Agents | 2000 |